QSS
RCUS icon

Quantitative Systematic Strategies’s Arcus Biosciences RCUS Stock Holding History

Quantitative Systematic Strategies’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,759
Closed -$116K – 587
2018
Q4 		$116K Buy
+10,759
New +$126K 0.03% 597

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Quantitative Systematic Strategies's RCUS Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of Arcus Biosciences (RCUS) in Q1 2019, closing a stake of 10,759 shares — an estimated $116K sold.

Quantitative Systematic Strategies first reported a position in RCUS in Q4 2018 and held it in 1 quarter. The position peaked at $116K in Q4 2018. 64 funds tracked by Wall St. Rank hold RCUS as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining Arcus Biosciences position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 10,759 Arcus Biosciences shares in Q1 2019, an estimated $116K.
  • Quantitative Systematic Strategies first reported a position in Arcus Biosciences in Q4 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Arcus Biosciences position peaked at $116K in Q4 2018.
  • 64 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.